1-[(6Z,9Z,12Z,15Z)-octadecatetraenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycerol

Term ID

CHEBI:87246

Synonyms

(2S)-1-hydroxy-3-{[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy}propan-2-yl (4Z,7Z,10Z,13Z,16ZZ,19Z)-docosa-4,7,10,13,16,19-hexaenoate
DAG(18:4n3/22:6n3)
DAG(18:4w3/22:6w3)
DG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
DG(18:4n3/22:6n3)
Diacylglycerol(18:4w3/22:6w3)

Definition

A diacylglycerol 40:10 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z,15Z)-octadecatetraenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

HMDB:HMDB0007353
LIPID_MAPS_instance:LMGL02010521

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycerol diacylglycerol 40:10

1,2-diacyl-sn-glycerol diacylglycerol 40:10 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid all-cis-octadeca-6,9,12,15-tetraenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid all-cis-octadeca-6,9,12,15-tetraenoic acid Show first 5 Terms

Phenotype

Phenotype resulting from 1-[(6Z,9Z,12Z,15Z)-octadecatetraenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycerol

Phenotype where environments contain 1-[(6Z,9Z,12Z,15Z)-octadecatetraenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycerol

Phenotype modified by environments containing 1-[(6Z,9Z,12Z,15Z)-octadecatetraenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycerol

Human Disease Model